Physician profile

Bilal A Khan

Gastroenterology (Internal Medicine) · Rockwall, TX

NPI 1417917436

$5,437.58

in general payments reported to CMS, 2019-2025

31 companies · $16.87 in 2025

The $16.87 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

See the full distribution for Gastroenterology (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,735.21

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $2,537.12 2019-2025
Janssen Biotech, INC. $479.34 2019-2023 Stelara
Takeda Pharmaceuticals U.S.A., INC. $428.70 2019-2023 Entyvio
Ferring Pharmaceuticals INC. $268.96 2019-2022
Ironwood Pharmaceuticals, INC $165.09 2019-2023 Linzess
Amgen INC. $159.39 2021-2023 Avsola, Amjevita
Genentech USA, INC. $147.35 2019
Penumbra, INC. $136.18 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $131.98 2019-2023 Trulance
Inari Medical, INC. $119.52 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Regeneron Healthcare Solutions, INC. $81.89 2023 Dupixent
Alfasigma USA, INC. $79.50 2020
Intercept Pharmaceuticals, INC. $79.13 2022-2023 Ocaliva
Genzyme Corporation $78.54 2022-2023
Redhill Biopharma INC. $73.53 2020-2023 Movantik, Talicia, Aemcolo
Show all 30 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $70.05 2023
Ucb, INC. $41.40 2019
Daiichi Sankyo INC. $40.86 2020-2023 Injectafer
Allergan, INC. $36.29 2019-2020
Organon LLC $35.21 2023 Renflexis, Hadlima
Merck Sharp & Dohme LLC $33.18 2021
Gilead Sciences, INC. $31.48 2024
Celgene Corporation $30.30 2021
Braintree Laboratories, INC. $28.97 2022
Medtronic, INC. $26.41 2021-2023 Nexpowder
Alnylam Pharmaceuticals INC. $25.65 2023 Oxlumo
Ardelyx, INC. $23.55 2022
Abbott Laboratories $18.04 2019
Amag Pharmaceuticals, INC. $16.01 2021
Shionogi INC $13.96 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$19,346.90 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bilal A Khan

$5,437.58

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $16.87 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

https://glasscript.com/doctor/336239/bilal-a-khan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.